{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:37:52Z","timestamp":1792175872310,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Janus kinase 3 (JAK3) acts downstream of the interleukin-2 (IL-2) receptor family to play a pivotal role in the regulation of lymphoid cell development. Activating JAK3 mutations are associated with a number of lymphoid and other malignancies, with mutations within the regulatory pseudokinase domain common.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The pseudokinase domain mutations A572V and A573V were separately introduced into the highly conserved zebrafish Jak3 and transiently expressed in cell lines and zebrafish embryos to examine their\u00a0activity and impact on early T cells. Genome editing was subsequently used to introduce the A573V mutation into the zebrafish genome to study the effects of JAK3 activation on lymphoid cells in a physiologically relevant context throughout the life-course.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Zebrafish Jak3 A573V produced the strongest activation of downstream STAT5 in vitro and elicited a significant increase in T cells in zebrafish embryos. Zebrafish carrying just a single copy of the Jak3 A573V allele displayed elevated embryonic T cells, which continued into adulthood. Hematopoietic precursors and NK cells were also increased, but not B cells. The lymphoproliferative effects of Jak3 A573V in embryos was shown to be dependent on zebrafish IL-2R\u03b3c, JAK1 and STAT5B equivalents, and could be suppressed with the JAK3 inhibitor Tofacitinib.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates that a single JAK3 A573V allele expressed from the endogenous locus was able to enhance lymphopoiesis throughout the life-course, which was mediated via an IL-2R\u03b3c\/JAK1\/JAK3\/STAT5 signaling pathway and was sensitive to Tofacitinib. This extends our understanding of oncogenic JAK3 mutations and creates a novel model to underpin further translational investigations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00018-022-04361-8","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T15:02:58Z","timestamp":1653663778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In vivo impact of JAK3 A573V mutation revealed using zebrafish"],"prefix":"10.1007","volume":"79","author":[{"given":"Faiza","family":"Basheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilasha","family":"Bulleeraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet Q. T.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Liongue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-7975","authenticated-orcid":false,"given":"Alister C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"4361_CR1","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/onc.2014.243","volume":"34","author":"A Agarwal","year":"2015","unstructured":"Agarwal A, MacKenzie RJ, Eide CA, Davare MA, Watanabe-Smith K, Tognon CE et al (2015) Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia. Oncogene 34:2991\u20132999","journal-title":"Oncogene"},{"key":"4361_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152464","volume":"131","author":"S Avagyan","year":"2021","unstructured":"Avagyan S (2021) Brown AL To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition. J Clin Investig 131:e152464","journal-title":"J Clin Investig"},{"key":"4361_CR3","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/leu.2012.74","volume":"26","author":"T Bains","year":"2012","unstructured":"Bains T, Heinrich M, Loriaux M, Beadling C, Nelson D, Warrick A et al (2012) Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 26:2144\u20132146","journal-title":"Leukemia"},{"key":"4361_CR4","doi-asserted-by":"publisher","first-page":"e00793","DOI":"10.1128\/IAI.00793-18","volume":"87","author":"F Basheer","year":"2019","unstructured":"Basheer F, Rasighaemi P, Liongue C (2019) Ward AC Zebrafish granulocyte colony-stimulating factor receptor maintains neutrophil number and function throughout the life span. Infect Immun 87:e00793-e818","journal-title":"Infect Immun"},{"key":"4361_CR5","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1182\/bloodadvances.2018019950","volume":"2","author":"CR Batista","year":"2018","unstructured":"Batista CR, Lim M, Laramee AS, Abu-Sardanah F, Xu LS, Hossain R et al (2018) Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B. Blood Adv 2:2798\u20132810","journal-title":"Blood Adv"},{"key":"4361_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/leu.2013.271","volume":"28","author":"D Bellanger","year":"2014","unstructured":"Bellanger D, Jacquemin V, Chopin M, Pierron G, Bernard O, Ghysdael J et al (2014) Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia. Leukemia 28:417\u2013419","journal-title":"Leukemia"},{"key":"4361_CR7","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1242\/dev.015297","volume":"135","author":"JY Bertrand","year":"2008","unstructured":"Bertrand JY, Kim AD, Teng S (2008) Traver D CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis. Development 135:1853\u20131862","journal-title":"Development"},{"key":"4361_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/leu.2013.157","volume":"28","author":"A Bouchekioua","year":"2014","unstructured":"Bouchekioua A, Scourzic L, De Wever O, Zhang Y, Cervera P, Aline-Fardin A et al (2014) JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia 28:338\u2013348","journal-title":"Leukemia"},{"key":"4361_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1182\/blood.2019000015","volume":"134","author":"M Broux","year":"2019","unstructured":"Broux M, Prieto C, Demeyer S, Vanden Bempt M, Alberti-Servera L, Lodewijckx I et al (2019) Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Blood 134:1323\u20131336","journal-title":"Blood"},{"key":"4361_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00792599","volume":"19","author":"F Candotti","year":"1998","unstructured":"Candotti F, O\u2019Shea JJ (1998) Villa A Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway. Springer Semin Immunopathol 19:401\u2013415","journal-title":"Springer Semin Immunopathol"},{"key":"4361_CR11","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1182\/blood-2008-06-164368","volume":"113","author":"MG Cornejo","year":"2009","unstructured":"Cornejo MG, Kharas MG, Werneck MB, Le Bras S, Moore SA, Ball B et al (2009) Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood 113:2746\u20132754","journal-title":"Blood"},{"key":"4361_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2020.10.022","volume":"147","author":"W Damsky","year":"2021","unstructured":"Damsky W, Peterson D, Ramseier J, Al-Bawardy B, Chun H, Proctor D et al (2021) The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. J Allergy Clin Immunol 147:814\u2013826","journal-title":"J Allergy Clin Immunol"},{"key":"4361_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.dci.2003.12.003","volume":"28","author":"N Danilova","year":"2004","unstructured":"Danilova N, Hohman VS, Sacher F, Ota T, Willett CE (2004) Steiner LA T cells and the thymus in developing zebrafish. Dev Comp Immunol 28:755\u2013767","journal-title":"Dev Comp Immunol"},{"key":"4361_CR14","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41375-018-0127-8","volume":"32","author":"J De Bie","year":"2018","unstructured":"De Bie J, Demeyer S, Alberti-Servera L, Geerdens E, Segers H, Broux M et al (2018) Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia. Leukemia 32:1358\u20131369","journal-title":"Leukemia"},{"key":"4361_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/2159-8290.CD-17-0583","volume":"8","author":"CE de Bock","year":"2018","unstructured":"de Bock CE, Demeyer S, Degryse S, Verbeke D, Sweron B, Gielen O et al (2018) HOXA9 cooperates with activated JAK\/STAT signaling to drive leukemia development. Cancer Discov 8:616\u2013631","journal-title":"Cancer Discov"},{"key":"4361_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1182\/blood-2017-07-797597","volume":"131","author":"S Degryse","year":"2018","unstructured":"Degryse S, Bornschein S, de Bock CE, Leroy E, Vanden Bempt M, Demeyer S et al (2018) Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL. Blood 131:421\u2013425","journal-title":"Blood"},{"key":"4361_CR17","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","volume":"124","author":"S Degryse","year":"2014","unstructured":"Degryse S, De Bock CE, Cox L, Demeyer S, Gielen O, Mentens N et al (2014) JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model. Blood 124:3092\u20133100","journal-title":"Blood"},{"key":"4361_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273\u2013287","journal-title":"Immunol Rev"},{"key":"4361_CR19","first-page":"PO.17.00019","volume":"2018","author":"A Greenplate","year":"2018","unstructured":"Greenplate A, Wang K, Tripathi RM, Palma N, Ali SM, Stephens PJ et al (2018) Genomic profiling of T-cell neoplasms reveals frequent JAK1 and JAK3 mutations with clonal evasion from targeted therapies. JCO Precis Oncol 2018:PO.17.00019","journal-title":"JCO Precis Oncol"},{"key":"4361_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.chembiol.2011.01.012","volume":"18","author":"C Haan","year":"2011","unstructured":"Haan C, Rolvering C, Raulf F, Kapp M, Druckes P, Thoma G et al (2011) Jak1 has a dominant role over Jak3 in signal transduction through gammac-containing cytokine receptors. Chem Biol 18:314\u2013323","journal-title":"Chem Biol"},{"key":"4361_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nbt.2501","volume":"31","author":"WY Hwang","year":"2013","unstructured":"Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD et al (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227\u2013229","journal-title":"Nat Biotechnol"},{"key":"4361_CR22","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1084\/jem.188.11.2067","volume":"188","author":"K Imada","year":"1998","unstructured":"Imada K, Bloom ET, Nakajima H, Horvath-Arcidiacono JA, Udy GB, Davey HW et al (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med 188:2067\u20132074","journal-title":"J Exp Med"},{"key":"4361_CR23","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.4049\/jimmunol.1003907","volume":"186","author":"N Iwanami","year":"2011","unstructured":"Iwanami N, Mateos F, Hess I, Riffel N, Soza-Ried C, Schorpp M et al (2011) Genetic evidence for an evolutionarily conserved role of IL-7 signaling in T cell development of zebrafish. J Immunol 186:7060\u20137066","journal-title":"J Immunol"},{"key":"4361_CR24","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1073\/pnas.1721678115","volume":"115","author":"L Jamrog","year":"2018","unstructured":"Jamrog L, Chemin G, Fregona V, Coster L, Pasquet M, Oudinet C et al (2018) PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proc Natl Acad Sci USA 115:10357\u201310362","journal-title":"Proc Natl Acad Sci USA"},{"key":"4361_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sj.leu.2404527","volume":"21","author":"H Kiyoi","year":"2007","unstructured":"Kiyoi H, Yamaji S, Kojima S, Naoe T (2007) JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 21:574\u2013576","journal-title":"Leukemia"},{"key":"4361_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41375-018-0369-5","volume":"33","author":"S Kollmann","year":"2019","unstructured":"Kollmann S, Grundschober E, Maurer B, Warsch W, Grausenburger R, Edlinger L et al (2019) Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR\/ABL-induced leukemia. Leukemia 33:1583\u20131597","journal-title":"Leukemia"},{"key":"4361_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","volume":"2","author":"GC Koo","year":"2012","unstructured":"Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L et al (2012) Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma. Cancer Disc 2:591\u2013597","journal-title":"Cancer Disc"},{"key":"4361_CR28","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1073\/pnas.0402248101","volume":"101","author":"DM Langenau","year":"2004","unstructured":"Langenau DM, Ferrando AA, Traver D, Kutok JL, Hezel JP, Kanki JP et al (2004) In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci USA 101:7369\u20137374","journal-title":"Proc Natl Acad Sci USA"},{"key":"4361_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nri1590","volume":"5","author":"DM Langenau","year":"2005","unstructured":"Langenau DM, Zon LI (2005) The zebrafish: a new model of T-cell and thymic development. Nat Rev Immunol 5:307\u2013317","journal-title":"Nat Rev Immunol"},{"key":"4361_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1067\/mai.2000.106899","volume":"105","author":"WJ Leonard","year":"2000","unstructured":"Leonard WJ, Lin J-X (2000) Cytokine receptor signaling pathways. J Allergy Clin Immunol 105:877\u2013888","journal-title":"J Allergy Clin Immunol"},{"key":"4361_CR31","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard WJ, Lin JX, O\u2019Shea JJ (2019) The gammac family of cytokines: basic biology to therapeutic ramifications. Immunity 50:832\u2013850","journal-title":"Immunity"},{"key":"4361_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exphem.2005.11.003","volume":"34","author":"RS Lewis","year":"2006","unstructured":"Lewis RS, Stephenson SEM, Ward AC (2006) Constitutive activation of zebrafish stat5 expands hematopoietic cell populations in vivo. Exp Hematol 34:179\u2013187","journal-title":"Exp Hematol"},{"key":"4361_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gene.2004.05.012","volume":"338","author":"RS Lewis","year":"2004","unstructured":"Lewis RS, Ward AC (2004) Conservation, duplication and divergence of the zebrafish stat5 genes. Gene 338:65\u201374","journal-title":"Gene"},{"key":"4361_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao W, Lin JX, Leonard WJ (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38:13\u201325","journal-title":"Immunity"},{"key":"4361_CR35","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1182\/blood.V98.10.3087","volume":"98","author":"GJ Lieschke","year":"2001","unstructured":"Lieschke GJ, Oates AC, Crowhurst MO, Ward AC, Layton JE (2001) Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 98:3087\u20133096","journal-title":"Blood"},{"key":"4361_CR36","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/sj.onc.1203523","volume":"19","author":"JX Lin","year":"2000","unstructured":"Lin JX, Leonard WJ (2000) The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19:2566\u20132576","journal-title":"Oncogene"},{"key":"4361_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032777","volume":"7","author":"C Liongue","year":"2012","unstructured":"Liongue C, O\u2019Sullivan LA, Trengove MC (2012) Ward AC Evolution of JAK-STAT pathway components: mechanisms and role in immune system development. PLoS ONE 7:e32777","journal-title":"PLoS ONE"},{"key":"4361_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2148-7-120","volume":"7","author":"C Liongue","year":"2007","unstructured":"Liongue C, Ward AC (2007) Evolution of class I cytokine receptors. BMC Evol Biol 7:120","journal-title":"BMC Evol Biol"},{"key":"4361_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0925-4773(01)00658-X","volume":"113","author":"F Liu","year":"2002","unstructured":"Liu F, Wen Z (2002) Cloning and expression pattern of the lysozyme C gene in zebrafish. Mech Dev 113:69\u201372","journal-title":"Mech Dev"},{"key":"4361_CR40","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR et al (2017) The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet 49:1211\u20131218","journal-title":"Nat Genet"},{"key":"4361_CR41","doi-asserted-by":"publisher","first-page":"29022","DOI":"10.1074\/jbc.M115.670224","volume":"290","author":"E Losdyck","year":"2015","unstructured":"Losdyck E, Hornakova T, Springuel L, Degryse S, Gielen O, Cools J et al (2015) Distinct acute lymphoblastic leukemia (ALL)-associated Janus kinase 3 (JAK3) mutants exhibit different cytokine-receptor requirements and JAK inhibitor specificities. J Biol Chem 290:29022\u201329034","journal-title":"J Biol Chem"},{"key":"4361_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","volume":"148","author":"Y Luo","year":"2021","unstructured":"Luo Y, Alexander M, Gadina M, O\u2019Shea JJ, Meylan F (2021) Schwartz DM JAK-STAT signaling in human disease: from genetic syndromes to clinical inhibition. J Allergy Clin Immunol 148:911\u2013925","journal-title":"J Allergy Clin Immunol"},{"key":"4361_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","volume":"33","author":"TR Malek","year":"2010","unstructured":"Malek TR, Castro I (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153\u2013165","journal-title":"Immunity"},{"key":"4361_CR44","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1182\/blood-2008-01-136366","volume":"112","author":"S Malinge","year":"2008","unstructured":"Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C et al (2008) Activating mutations in human acute megakaryoblastic leukemia. Blood 112:4220\u20134226","journal-title":"Blood"},{"key":"4361_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","volume":"126","author":"LY McGirt","year":"2015","unstructured":"McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA et al (2015) Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 126:508\u2013519","journal-title":"Blood"},{"key":"4361_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.20152013","volume":"213","author":"FE Moore","year":"2016","unstructured":"Moore FE, Garcia EG, Lobbardi R, Jain E, Tang Q, Moore JC et al (2016) Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish. J Exp Med 213:979\u2013992","journal-title":"J Exp Med"},{"key":"4361_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","volume":"10","author":"R Moriggl","year":"1999","unstructured":"Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D et al (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249\u2013259","journal-title":"Immunity"},{"key":"4361_CR48","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1073\/pnas.0811761106","volume":"106","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, Phillips LA et al (2009) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 106:9414\u20139418","journal-title":"Proc Natl Acad Sci USA"},{"key":"4361_CR49","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1038\/leu.2016.178","volume":"30","author":"A Nicolae","year":"2016","unstructured":"Nicolae A, Xi L, Pham TH, Pham TA, Navarro W, Meeker HG et al (2016) Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia 30:2245\u20132247","journal-title":"Leukemia"},{"key":"4361_CR50","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","volume":"44","author":"LA O'Sullivan","year":"2007","unstructured":"O\u2019Sullivan LA, Liongue C, Lewis RS, Stephenson SEM, Ward AC (2007) Cytokine receptor signaling through the Jak\/Stat\/Socs pathway in disease. Mol Immunol 44:2497\u20132506","journal-title":"Mol Immunol"},{"key":"4361_CR51","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2012-12-471029","volume":"122","author":"DM Page","year":"2013","unstructured":"Page DM, Wittamer V, Bertrand JY, Lewis KL, Pratt DN, Delgado N et al (2013) An evolutionarily conserved program of B-cell development and activation in zebrafish. Blood 122:e1\u2013e11","journal-title":"Blood"},{"key":"4361_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1172\/JCI94509","volume":"128","author":"HTT Pham","year":"2018","unstructured":"Pham HTT, Maurer B, Prchal-Murphy M, Grausenburger R, Grundschober E, Javaheri T et al (2018) STAT5BN642H is a driver mutation for T cell neoplasia. J Clin Investig 128:387\u2013401","journal-title":"J Clin Investig"},{"key":"4361_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/cancers13040800","volume":"13","author":"J Raivola","year":"2021","unstructured":"Raivola J, Haikarainen T, Abraham BG, Silvennoinen O (2021) Janus kinases in leukemia. Cancers (Basel) 13:800","journal-title":"Cancers (Basel)"},{"key":"4361_CR54","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fonc.2018.00560","volume":"8","author":"J Raivola","year":"2018","unstructured":"Raivola J, Hammaren HM, Virtanen AT, Bulleeraz V, Ward AC, Silvennoinen O (2018) Hyperactivation of oncogenic JAK3 mutants depend on ATP binding to the pseudokinase domain. Front Oncol 8:560","journal-title":"Front Oncol"},{"key":"4361_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-015-0126-4","volume":"8","author":"P Rasighaemi","year":"2015","unstructured":"Rasighaemi P, Basheer F, Liongue C, Liongue C, Ward AC (2015) Zebrafish as a model for leukemia and other hematopoietic disorders. J Hematol Oncol 8:29","journal-title":"J Hematol Oncol"},{"key":"4361_CR56","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3109\/10428194.2011.574757","volume":"52","author":"L Riera","year":"2011","unstructured":"Riera L, Lasorsa E, Bonello L, Sismondi F, Tondat F, Di Bello C et al (2011) Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. Leuk Lymphoma 52:1742\u20131750","journal-title":"Leuk Lymphoma"},{"key":"4361_CR57","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1182\/bloodadvances.2018016089","volume":"2","author":"P Rivera-Munoz","year":"2018","unstructured":"Rivera-Munoz P, Laurent AP, Siret A, Lopez CK, Ignacimouttou C, Cornejo MG et al (2018) Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models. Blood Adv 2:1616\u20131627","journal-title":"Blood Adv"},{"key":"4361_CR58","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1038\/sj.onc.1210756","volume":"26","author":"L Robb","year":"2007","unstructured":"Robb L (2007) Cytokine receptors and hematopoietic differentiation. Oncogene 26:6715\u20136723","journal-title":"Oncogene"},{"key":"4361_CR59","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3390\/ijms23042385","volume":"23","author":"R Sertori","year":"2022","unstructured":"Sertori R, Jones R, Basheer F, Rivera L, Dawson S, Loke S et al (2022) Generation and characterization of a zebrafish IL-2Rgc SCID model. Int J Mol Sci 23:2385","journal-title":"Int J Mol Sci"},{"key":"4361_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4049\/jimmunol.1403060","volume":"196","author":"R Sertori","year":"2016","unstructured":"Sertori R, Liongue C, Basheer F, Lewis KL, Rasighaemi P, de Coninck D et al (2016) Conserved IL-2Rgc signaling mediates lymphopoiesis in zebrafish. J Immunol 196:135\u2013143","journal-title":"J Immunol"},{"key":"4361_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/bfgp\/elv051","volume":"15","author":"R Sertori","year":"2016","unstructured":"Sertori R, Trengove M, Basheer F, Ward AC, Liongue C (2016) Genome editing in zebrafish: a practical overview. Brief Funct Genom 15:322\u2013330","journal-title":"Brief Funct Genom"},{"key":"4361_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nprot.2007.514","volume":"3","author":"C Thisse","year":"2008","unstructured":"Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3:59\u201369","journal-title":"Nat Protoc"},{"key":"4361_CR63","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3390\/cancers11121833","volume":"11","author":"L Wahnschaffe","year":"2019","unstructured":"Wahnschaffe L, Braun T, Timonen S, Giri AK, Schrader A, Wagle P et al (2019) JAK\/STAT-activating genomic alterations are a hallmark of T-PLL. Cancers (Basel) 11:1833","journal-title":"Cancers (Basel)"},{"key":"4361_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ccr.2006.06.002","volume":"10","author":"DK Walters","year":"2006","unstructured":"Walters DK, Mercher T, Gu TL, O\u2019Hare T, Tyner JW, Loriaux M et al (2006) Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 10:65\u201375","journal-title":"Cancer Cell"},{"key":"4361_CR65","volume-title":"The zebrafish book","author":"M Westerfield","year":"1995","unstructured":"Westerfield M (1995) The zebrafish book, 3rd edn. University of Oregon Press, Eugene","edition":"3"},{"key":"4361_CR66","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/dvdy.1223","volume":"222","author":"CE Willett","year":"2001","unstructured":"Willett CE, Kawasaki H, Amemiya CT, Lin S, Steiner LA (2001) Ikaros expression as a marker for lymphoid progenitors during zebrafish development. Dev Dyn 222:694\u2013698","journal-title":"Dev Dyn"},{"key":"4361_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/dbio.1996.8446","volume":"182","author":"CE Willett","year":"1997","unstructured":"Willett CE, Zapata A, Hopkins N, Steiner LA (1997) Expression of zebrafish rag genes during early development identifies the thymus. Dev Biol 182:331\u2013341","journal-title":"Dev Biol"},{"key":"4361_CR68","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jgg.2017.07.006","volume":"44","author":"S Xiong","year":"2017","unstructured":"Xiong S, Mei J, Huang P, Jing J, Li Z, Kang J et al (2017) Essential roles of stat5.1\/stat5b in controlling fish somatic growth. J Genet Genom 44:577\u2013585","journal-title":"J Genet Genom"},{"key":"4361_CR69","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41375-021-01392-1","volume":"36","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wang X, Hou S, Guo T, Lan Y, Yang S et al (2022) PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression. Leukemia 36:370\u2013382","journal-title":"Leukemia"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04361-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04361-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T13:11:59Z","timestamp":1656162719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04361-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4361"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04361-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Deakin University Animal Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"322"}}